Company intelligence / Profile preview
Privo Technologies, Inc.
Peabody, Massachusetts, United Statesprivotechnologies.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Privo Technologies has developed a proprietary nanotechnology-based drug delivery platform for locoregional chemotherapy. Its lead product PRV111—a nanoengineered patch delivering cisplatin directly to tumor sites—has shown over a 70% reduction in tumor volume within one week with no dose-limiting toxicities in phase II trials for oral cavity cancer. The company’s CLN‑004 trial evaluates both PRV111 and intraoperative system PRV211 across leading US cancer centers. Both products aim to maximize efficacy while minimizing systemic toxicity. The company has received significant non-dilutive funding from NIH/NCI/FDA and plans pivotal global phase III studies targeting head & neck cancers.
- Therapeutic areas
- Oncology
- Modalities
- Nanoparticle-based drug delivery (cisplatin nanoparticles)Small molecules (cisplatin)Potential for proteins, biologics, nucleotides in future PRV derivatives
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Collaborations with FDANational Cancer Institute (NCI)National Institute of Dental and Craniofacial Research (NIDCR)major US academic medical centers participating as trial sites include University of Chicago MedicineCity of HopeMiami Cancer InstituteCleveland Clinic.
Beyond the preview
Go deeper on Privo Technologies, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Privo Technologies, Inc..